Health inequalities and systemic lupus erythematosus: a global challenge.
作者信息
Bruce Ian N
机构信息
Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
出版信息
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i1-i3. doi: 10.1093/rheumatology/kead058.
Abstract
摘要
相似文献
1
Health inequalities and systemic lupus erythematosus: a global challenge.健康不平等与系统性红斑狼疮：一项全球挑战。
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i1-i3. doi: 10.1093/rheumatology/kead058.
2
Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).儿童系统性红斑狼疮的疾病活动度和损伤评估指标：不列颠群岛狼疮评估组（BILAG）、欧洲狼疮活动度共识测量法（ECLAM）、系统性狼疮活动度测量法（SLAM）、系统性红斑狼疮疾病活动指数（SLEDAI）、医生对疾病活动度的整体评估（MD整体评估）以及系统性红斑狼疮国际协作临床中心/美国风湿病学会损伤指数（SLICC/ACR DI；SDI）。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S112-7. doi: 10.1002/acr.20623.
3
Worsening skin damage in patients with cutaneous lupus erythematosus may predict development of systemic lupus erythematosus.皮肤型红斑狼疮患者皮肤损伤的恶化可能预示着系统性红斑狼疮的发生。
J Am Acad Dermatol. 2021 Feb;84(2):538-540. doi: 10.1016/j.jaad.2020.05.020. Epub 2020 May 11.
4
Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus.基线疾病活动度、高脂血症和高血压是系统性红斑狼疮患者缺血性卒中及卒中严重程度的预测因素。
Stroke. 2007 Feb;38(2):281-5. doi: 10.1161/01.STR.0000254476.05620.14. Epub 2007 Jan 11.
5
Canadian workplace experiences of systemic lupus erythematosus (SLE).加拿大系统性红斑狼疮（SLE）的职场经历。
Lupus Sci Med. 2021 Sep;8(1). doi: 10.1136/lupus-2021-000536.
6
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).疾病活动对系统性红斑狼疮患者健康相关生活质量的影响——瑞士系统性红斑狼疮队列研究（SSCS）的横断面分析
BMC Immunol. 2017 Mar 28;18(1):17. doi: 10.1186/s12865-017-0200-5.
7
Is chronic periodontitis premature in systemic lupus erythematosus patients?系统性红斑狼疮患者是否会过早患上慢性牙周炎？
Clin Rheumatol. 2017 Mar;36(3):713-718. doi: 10.1007/s10067-016-3385-8. Epub 2016 Aug 24.
8
Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study.系统性红斑狼疮患儿神经精神症状的危险因素：病例对照研究。
Pediatr Neurol. 2014 Sep;51(3):403-9. doi: 10.1016/j.pediatrneurol.2014.03.027. Epub 2014 Apr 2.
9
Tuberculosis and systemic lupus erythematosus: a case-control study in Mexico City.结核与系统性红斑狼疮：墨西哥城的一项病例对照研究。
Clin Rheumatol. 2018 Aug;37(8):2095-2102. doi: 10.1007/s10067-018-4109-z. Epub 2018 Apr 20.
10
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome.系统性红斑狼疮的周围神经系统受累：一项关于患病率、相关因素及预后的回顾性研究
Lupus. 2019 Apr;28(4):465-474. doi: 10.1177/0961203319828499. Epub 2019 Feb 10.
引用本文的文献
1
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide.欧洲和全球系统性红斑狼疮患者获得医疗服务的挑战与机遇。
Rheumatology (Oxford). 2024 Jul 1;63(7):1772-1778. doi: 10.1093/rheumatology/keae227.
本文引用的文献
1
Dilemma of immunosuppression and infection risk in systemic lupus erythematosus.系统性红斑狼疮中免疫抑制与感染风险的困境。
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i22-i29. doi: 10.1093/rheumatology/keac678.
2
The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus.社会决定因素对系统性红斑狼疮的表现、治疗和结局的影响。
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i10-i14. doi: 10.1093/rheumatology/keac613.
3
Improving access to SLE therapies in low and middle-income countries.改善中低收入国家 SLE 治疗方法的可及性。
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i30-i35. doi: 10.1093/rheumatology/keac530.
4
The global epidemiology of SLE: narrowing the knowledge gaps.系统性红斑狼疮的全球流行病学：缩小知识差距。
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i4-i9. doi: 10.1093/rheumatology/keac610.
5
Genetics of SLE: does this explain susceptibility and severity across racial groups?SLE 的遗传学：这是否可以解释不同种族人群的易感性和严重程度？
Rheumatology (Oxford). 2023 Mar 29;62(Suppl 1):i15-i21. doi: 10.1093/rheumatology/keac695.
6
Global epidemiology of systemic lupus erythematosus.系统性红斑狼疮的全球流行病学。
Nat Rev Rheumatol. 2021 Sep;17(9):515-532. doi: 10.1038/s41584-021-00668-1. Epub 2021 Aug 3.
7
Age differences in secular trends in black-white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017.1988年至2017年美国女性系统性红斑狼疮死亡率的黑白差异长期趋势中的年龄差异
Lupus. 2021 Apr;30(5):715-724. doi: 10.1177/0961203321988936. Epub 2021 Feb 3.
8
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.利妥昔单抗治疗难治性系统性红斑狼疮的短期疗效和安全性：来自不列颠狼疮评估组生物制剂登记处的结果。
Rheumatology (Oxford). 2018 Mar 1;57(3):470-479. doi: 10.1093/rheumatology/kex395.
9
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.系统性红斑狼疮的总体死亡率和特定病因死亡率：一项更新的荟萃分析。
Lupus. 2016 Jun;25(7):727-34. doi: 10.1177/0961203315627202. Epub 2016 Jan 24.
10
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.2000 - 2004年美国有医疗补助覆盖的成年人中系统性红斑狼疮和狼疮性肾炎的流行病学及社会人口统计学特征
Arthritis Rheum. 2013 Mar;65(3):753-63. doi: 10.1002/art.37795.
Zotero 插件